Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - FIBROGEN INC | fgen-ex321_10.htm |
| EX-31.2 - EX-31.2 - FIBROGEN INC | fgen-ex312_9.htm |
| EX-31.1 - EX-31.1 - FIBROGEN INC | fgen-ex311_6.htm |
| EX-10.35 - EX-10.35 - FIBROGEN INC | fgen-ex1035_673.htm |
| EX-10.34 - EX-10.34 - FIBROGEN INC | fgen-ex1034_242.htm |
| EX-10.33 - EX-10.33 - FIBROGEN INC | fgen-ex1033_241.htm |
| EX-10.32 - EX-10.32 - FIBROGEN INC | fgen-ex1032_243.htm |
| EX-10.28 - EX-10.28 - FIBROGEN INC | fgen-ex1028_711.htm |
| EX-4.4 - EX-4.4 - FIBROGEN INC | fgen-ex44_244.htm |
| 10-K - 10-K - FIBROGEN INC | fgen-10k_20191231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-200348, No. 333-213816, No. 333-216369, and No. 333-233204) of FibroGen, Inc. of our report dated March 2, 2020 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 2, 2020